Polymorphisms of CAK genes and risk for lung cancer: A case-control study in Chinese population

Lung Cancer

Volumn 58, Issue 2, 2007, Pages 171-183

  Li, Yuanchun ^a   Jin, Guangfu ^b   Wang, Haifeng ^c   Liu, Hongliang ^a   Qian, Ji ^a   Gu, Shaohua ^a   Ma, Hongxia ^b   Miao, Ruifeng ^b   Hu, Zhibin ^b   Sun, Weiwei ^c   Wang, Yi ^c   Jin, Li ^a,c   Wei, Qingyi ^d   Shen, Hongbing ^b   Huang, Wei ^c   Lu, Daru ^a  

^a FUDAN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CAK genes; Genetic polymorphisms; Haplotype; Lung cancer; MDR; Molecular epidemiology

Indexed keywords

CYCLIN DEPENDENT KINASE 7; CYCLIN H; CYCLINE; PROTEIN; PROTEIN MAT1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL CYCLE REGULATION; CHINESE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHINA; CYCLIN-DEPENDENT KINASES; CYCLINS; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SOFTWARE;

EID: 34848870028     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.06.016     Document Type: Article

References (52)

1. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking. vol. 38. Lyon: IARC; 1986,83-126.
2. Lee G.Y., Jang J.S., Lee S.Y., Jeon H.S., Kim K.M., Choi J.E., et al. XPC polymorphisms and lung cancer risk. Int. J. Cancer 115 (2005) 807-813
3. Perera F.P., Mooney L.A., Stampfer M., Phillips D.H., Bell D.A., and Rundle A. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 23 10 (2002) 1641-1646
4. Benhamou S., and Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am. J. Epidemiol 161 1 (2005) 1-14
5. Collins K., Jacks T., and Pavletich N.P. The cell cycle and cancer. Proc Natl Acad Sci USA 94 (1997) 2776-2778
6. Fesquet D., Labbe J.C., Derancourt J., Capony J.P., Galas S., Girard F., et al. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J 12 (1993) 3111-3121
7. Poon R.Y.C., Yamashita K., Adamczewski J.P., Hunt T., and Shuttleworth J. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J 12 (1993) 3123-3132
8. Solomon M.J., Harper J.W., and Shuttleworth J. CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J 12 (1993) 3133-3142
9. Fisher R.P., and Morgan D.O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78 (1994) 713-724
10. Makela T.P., Tassan J.P., Nigg E.A., Frutiger S., Hughes G.J., and Weinberg R.A. A cyclin associated with the CDK-activating kinase MO15. Nature 371 (1994) 254-257
11. Fisher R.P., Jin P., Chamberlin H.M., and Morgan D.O. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83 (1995) 47-57
12. Devault A., Martinez A.M., Fesquet D., Labb6 J.C., Morin N., Cavadore J.C., et al. MAT1 ('menage a trois'), a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J 14 (1995) 5027-5036
13. Tassan J.P., Jaquenod M., Fry A.M., Frutiger S., Hughes G., and Nigg E.A. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J 14 (1995) 5608-5617
14. Tassan J.P., Schultz S.J., Bartek J., and Nigg E.A. Cell cycle analysis of the activity, subcellular localization, subunit composition of human CAK (CDK-activating kinase). J Cell Biol 127 (1994) 467-478
15. Adamczewski J.P., Rossignol M., Tassan J.P., Nigg E.A., Moncolin V., and Egly J.M. MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J 15 (1996) 1877-1884
16. Roy R., Adamczewski J.P., Seroz T., Vermeulen W., Tassan J.P., Schaeffer L., et al. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79 (1994) 1093-1101
17. Kaldis P. The cdk-activating kinase (CAK): from yeast to mammals. Cell Mol Life Sci 55 (1999) 284-296
18. Riedl T., and Egly J.M. Phosphorylation in transcription: the CTD and more. Gene Expr 9 (2000) 3-13
19. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-134
20. Usheva A., Maldonado E., Goldring A., Lu H., Houbavi C., Reinberg D., et al. Specific interaction between the nonphosphorylated form of RNA polymerase II and the TATA-binding protein. Cell 69 (1992) 871-881
21. Dvir A., Conaway R.C., and Conaway J.W. Promoter escape by RNA polymerase II, A role for an ATP cofactor in suppression of arrest by polymerase at promoter-proximal sites. J Biol Chem 271 (1996) 23352-23356
22. Schaeffer L., Roy R., Humbert S., Moncollin V., Vermeulen W., Hoeijmakers J.H.J., et al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260 (1993) 58-63
23. Feaver W.L., Svejstrup J.Q., Bardwell L., Bardwell A.J., Buratowsld S., Gulyas K.D., et al. Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair. Cell 75 (1993) 1379-1387
24. Wang Z., Svejstrup J.Q., Feaver W.J., Wu X., Kornberg R.D., and Friedberg E.C. Transcription factor β (TFIIH) is required during nucleotide-excision repair in yeast. Nature 368 (1994) 74-76
25. Drapkin R., Reardon J.T., Ansari A., Huang J.C., Zawel L., Ahn K., et al. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368 (1994) 769-772
26. Sandrock B., and Egly J. A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH. J Biol Chem 276 38 (2001) 35328-35333
27. Rochette-Egly C., Adam S., Rossignol M., Egly J.M., and Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90 (1997) 97-107
28. Bastien J., Adam-Stitah S., Riedl T., Egly J.M., Chambon P., and Rochette-Egly C. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7. J Biol Chem 275 (2000) 21896-21904
29. Kruglyak L., and Nickerson D.A. Variation is the spice of life. Nat Genet 27 3 (2001) 234-236
30. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., and Donnelly P. International HapMap consortium, a haplotype map of the human genome. Nature 437 7063 (2005) 1299-1320
31. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
32. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 73 (2003) 1162-1169
33. Ding K., Zhou K., He F., and Shen Y. LDA-a java-based linkage disequilibrium analyzer. Bioinformatics 19 (2003) 2147-2148
34. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59 (1995) 97-105
35. Wallenstein S., Hodge S.E., and Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 15 (1998) 173-181
36. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69 1 (2001) 138-147
37. Ritchie M.D., Hahn L.W., and Moore J.H. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24 2 (2003) 150-157
38. Hahn L.W., Ritchie M.D., and Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19 3 (2003) 376-382
39. Coffey C.S., Hebert P.R., Ritchie M.D., Krumholz H.M., Gaziano J.M., Ridker P.M., et al. An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics 5 (2004) 49
40. Andrew A.S., Nelson H.H., Kelsey K.T., Moore J.H., Meng A.C., Casella D.P., et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking, and bladder cancer susceptibility. Carcinogenesis 27 5 (2006) 1030-1037
41. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 296 5576 (2002) 2225-2229
42. Stram D.O., Haiman C.A., Hirschhorn J.N., Altshuler D., Kolonel L.N., Henderson B.E., et al. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 55 (2003) 27-36
43. Shields P.G., and Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18 (2000) 2309-2315
44. Mohrenweiser H.W., and Jones I.M. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promise and perils of individuals and population risk estimation?. Mutat Res 400 (1998) 15-24
45. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1513-1530
46. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet 17 (2001) 502-510
47. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
48. Harper J.W., and Elledge S.J. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev 12 (1998) 285-289
49. Schaid D.J., and Jacobsen S.J. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 149 (1999) 706-711
50. Wittke-Thompson J.K., Pluzhnikov A., and Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76 (2005) 967-986
51. Salanti G., Amountza G., Ntzani E.E., and Ioannidis J.P. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 13 (2005) 840-848
52. Radzikowska E., Roszkowski K., and Glaz P. Lung cancer in patients under 50 years old. Lung Cancer 33 (2001) 203-211